CORRECTION: Enlivex Therapeutics Reports Q1 Net Loss $7.2M Vs $8.2M YoY
Portfolio Pulse from Benzinga Newsdesk
Enlivex Therapeutics reported a Q1 net loss of $7.2 million, a decrease from the $8.2 million loss reported in the same period last year.
June 26, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Enlivex Therapeutics' Q1 net loss decreased to $7.2 million from $8.2 million YoY, potentially indicating improved financial performance.
Enlivex Therapeutics' Q1 net loss has decreased by $1 million compared to the same period last year, which may indicate an improvement in the company's financial performance. This could have a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100